Edition:
United States

People: Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

79.12EUR
11:35am EDT
Change (% chg)

€0.11 (+0.14%)
Prev Close
€79.01
Open
€79.49
Day's High
€80.13
Day's Low
€79.09
Volume
615,707
Avg. Vol
569,603
52-wk High
€89.22
52-wk Low
€70.69

Wanzek, Kent 

Mr. Kent Wanzek is Chief Executive Officer for Global Manufacturing & Quality, Member of the Management Board at Fresenius Medical Care AG & Co. KGaA since January 1, 2010. He has been the President for Operations of the Renal Therapies Group at Fresenius Medical Care North America since 2006. Prior to joining the Company in 2003, Mr. Wanzek had several senior executive positions including Philips Medical Systems and Baxter Healthcare Corporation.

Basic Compensation

Total Annual Compensation, EUR 1,705,000
Restricted Stock Awards, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 1,705,000
Fiscal Year Total, EUR 3,410,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gerd Krick

386,000

Rice Powell

7,532,000

Ben Lipps

4,862,000

Dieter Schenk

236,000

Michael Brosnan

4,380,000

Harry De Wit

2,572,000
As Of  30 Dec 2016